|Articles|May 7, 2004
Eyetech, Archemix join forces on aptamer research
Eyetech Pharmaceuticals and Archemix Corp. agreed to collaborate on the research and development of aptamers to develop for use in the treatment of ophthalmic diseases.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
AAO 2025: Kenneth C. Fan, MD, sees vision gains with MCO-010 in Stargardt disease
3
AAO 2025: Understanding and diagnosing endophthalmitis
4
Breaking down the barriers: Ophthalmic care in the incarcerated population
5